(BJUL) Innovator U.S. Equity - Ratings and Ratios
Flex Options, Defined Outcomes, S&P 500, Customizable Contracts
Description: BJUL Innovator U.S. Equity
The Innovator U.S. Equity Buffer ETF - July (BJUL) is an exchange-traded fund that employs a unique investment strategy, allocating at least 80% of its net assets to FLexible EXchange Options (FLEX Options) tied to the performance of the SPDR S&P 500 ETF Trust. This approach allows the fund to potentially benefit from the underlying ETFs performance while mitigating potential downsides through the customizable terms of FLEX Options.
Its crucial to understand that while FLEX Options are guaranteed by the Options Clearing Corporation (OCC), they still expose the fund to counterparty risk. Moreover, their liquidity may be compromised compared to traditional exchange-traded options. As a non-diversified fund, BJULs performance is heavily reliant on the referenced Underlying ETF, making it essential to closely monitor the S&P 500s movements.
Analyzing the available technical data, we observe that BJULs last price is $44.47, exceeding both its 20-day and 50-day Simple Moving Averages (SMA20 and SMA50) of $42.63 and $42.85, respectively. This indicates a positive short-term trend. Furthermore, the Average True Range (ATR) stands at 0.81, representing a 1.82% volatility. Considering the 52-week high and low of $46.09 and $39.61, respectively, BJUL has demonstrated resilience within the given price range.
With Assets Under Management (AUM) totaling $248.59 million, BJUL has a considerable presence in the Defined Outcome ETF category. By leveraging FLEX Options, the fund aims to provide a buffer against potential losses while still allowing for upside potential. Given the current technical and fundamental landscape, a forecast for BJUL could be constructed by examining the intersection of its technical indicators and the overall market conditions.
Assuming the S&P 500 continues to exhibit moderate volatility, BJULs use of FLEX Options could help mitigate potential losses. If the SMA20 and SMA50 continue to be surpassed by the last price, it may indicate a sustained upward trend. Consequently, a potential price target for BJUL could be near its 52-week high of $46.09, representing a 3.6% increase from the current price. However, a decline below the SMA50 could signal a reversal, potentially driving the price towards the 200-day Simple Moving Average (SMA200) of $43.76.
Additional Sources for BJUL ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
BJUL ETF Overview
Market Cap in USD | 234m |
Category | Defined Outcome |
TER | 0.79% |
IPO / Inception | 2018-08-28 |
BJUL ETF Ratings
Growth Rating | 71.8 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -1.91 |
Analysts | - |
Fair Price Momentum | 45.20 USD |
Fair Price DCF | - |
BJUL Dividends
Currently no dividends paidBJUL Growth Ratios
Growth Correlation 3m | 93.7% |
Growth Correlation 12m | 49.8% |
Growth Correlation 5y | 90.7% |
CAGR 5y | 11.50% |
CAGR/Max DD 5y | 0.82 |
Sharpe Ratio 12m | 1.27 |
Alpha | 1.03 |
Beta | 0.692 |
Volatility | 10.06% |
Current Volume | 138.8k |
Average Volume 20d | 10.4k |
As of July 02, 2025, the stock is trading at USD 47.14 with a total of 138,839 shares traded.
Over the past week, the price has changed by +1.86%, over one month by +4.50%, over three months by +8.99% and over the past year by +12.48%.
Yes. Based on ValueRay's Analyses, Innovator U.S. Equity (BATS:BJUL) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 71.75 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BJUL is around 45.20 USD . This means that BJUL is currently overvalued and has a potential downside of -4.12%.
Innovator U.S. Equity has no consensus analysts rating.
According to our own proprietary Forecast Model, BJUL Innovator U.S. Equity will be worth about 51.6 in July 2026. The stock is currently trading at 47.14. This means that the stock has a potential upside of +9.55%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 51.6 | 9.5% |